Cristina Garcia-Beltran1,2, Gemma Carreras-Badosa3, Judit Bassols4, Rita Malpique1,2, Cristina Plou1,2, Francis de Zegher5, Abel López-Bermejo3,6,7, Lourdes Ibáñez8,9. 1. Endocrinology Department, Pediatric Research Institute Hospital Sant Joan de Déu, University of Barcelona, 08950, Esplugues, Barcelona, Spain. 2. Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), ISCIII, 28029, Madrid, Spain. 3. Pediatric Endocrinology Research Group, Girona Institute for Biomedical Research, 17190, Salt, Spain. 4. Maternal-Fetal Metabolic Research Group, Girona Institute for Biomedical Research, 17190, Salt, Spain. 5. Department of Development & Regeneration, University of Leuven, 3000, Leuven, Belgium. 6. Department of Pediatrics, Dr. Josep Trueta Hospital, 17007, Girona, Spain. 7. Department of Medical Sciences, Faculty of Medicine. University of Girona, 17003, Girona, Spain. 8. Endocrinology Department, Pediatric Research Institute Hospital Sant Joan de Déu, University of Barcelona, 08950, Esplugues, Barcelona, Spain. lourdes.ibanez@sjd.es. 9. Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), ISCIII, 28029, Madrid, Spain. lourdes.ibanez@sjd.es.
Abstract
BACKGROUND: Children with low birth weight (LBW) have a higher risk of developing endocrine-metabolic disorders later in life. Deregulation of specific microRNAs (miRNAs) could underscore the programming of adult pathologies. We analyzed the miRNA expression pattern in both umbilical cord serum samples from LBW and appropriate-for-gestational-age (AGA) newborns and maternal serum samples in the 3rd trimester of gestation, and delineated the relationships with fetal growth, body composition, and markers of metabolic risk. METHODS: Serum samples of 12 selected mother-newborn pairs, including 6 LBW and 6 AGA newborns, were used for assessing miRNA profile by RNA-sequencing. The miRNAs with differential expression were validated in a larger cohort [49 maternal samples and 49 umbilical cord samples (24 LBW, 25 AGA)] by RT-qPCR. Anthropometric, endocrine-metabolic markers and body composition (by DXA) in infants were determined longitudinally over 12 months. RESULTS: LBW newborns presented reduced circulating concentrations of miR-191-3p (P = 0.015). miR-191-3p levels reliably differentiated LBW from AGA individuals (ROC AUC = 0.76) and were positively associated with anthropometric and body composition measures at birth and weight Z-score at 12 months (P < 0.05). CONCLUSIONS: miR-191-3p was reliably different in LBW individuals, and could be a new player in the epigenetic mechanisms linking LBW and future endocrine-metabolic adverse outcomes. IMPACT: Children with low birth weight (LBW) have a higher risk of developing endocrine-metabolic disorders. Deregulation of specific microRNAs (miRNAs) could underscore the programming of those pathologies. miR-191-3p is downregulated in serum of LBW newborns, and its concentrations associate positively with neonatal anthropometric measures, with lean mass and bone accretion at age 15 days and with weight Z-score at age 12 months. miR-191-3p was reliably different in individuals with LBW, and could be a new player in the epigenetic mechanisms connecting LBW and future endocrine-metabolic adverse outcomes.
BACKGROUND: Children with low birth weight (LBW) have a higher risk of developing endocrine-metabolic disorders later in life. Deregulation of specific microRNAs (miRNAs) could underscore the programming of adult pathologies. We analyzed the miRNA expression pattern in both umbilical cord serum samples from LBW and appropriate-for-gestational-age (AGA) newborns and maternal serum samples in the 3rd trimester of gestation, and delineated the relationships with fetal growth, body composition, and markers of metabolic risk. METHODS: Serum samples of 12 selected mother-newborn pairs, including 6 LBW and 6 AGA newborns, were used for assessing miRNA profile by RNA-sequencing. The miRNAs with differential expression were validated in a larger cohort [49 maternal samples and 49 umbilical cord samples (24 LBW, 25 AGA)] by RT-qPCR. Anthropometric, endocrine-metabolic markers and body composition (by DXA) in infants were determined longitudinally over 12 months. RESULTS: LBW newborns presented reduced circulating concentrations of miR-191-3p (P = 0.015). miR-191-3p levels reliably differentiated LBW from AGA individuals (ROC AUC = 0.76) and were positively associated with anthropometric and body composition measures at birth and weight Z-score at 12 months (P < 0.05). CONCLUSIONS: miR-191-3p was reliably different in LBW individuals, and could be a new player in the epigenetic mechanisms linking LBW and future endocrine-metabolic adverse outcomes. IMPACT: Children with low birth weight (LBW) have a higher risk of developing endocrine-metabolic disorders. Deregulation of specific microRNAs (miRNAs) could underscore the programming of those pathologies. miR-191-3p is downregulated in serum of LBW newborns, and its concentrations associate positively with neonatal anthropometric measures, with lean mass and bone accretion at age 15 days and with weight Z-score at age 12 months. miR-191-3p was reliably different in individuals with LBW, and could be a new player in the epigenetic mechanisms connecting LBW and future endocrine-metabolic adverse outcomes.
Authors: Rodosthenis S Rodosthenous; Heather H Burris; Alison P Sanders; Allan C Just; Alexandra E Dereix; Katherine Svensson; Maritsa Solano; Martha M Téllez-Rojo; Robert O Wright; Andrea A Baccarelli Journal: Epigenetics Date: 2017-09-26 Impact factor: 4.528
Authors: Daehyun Baek; Judit Villén; Chanseok Shin; Fernando D Camargo; Steven P Gygi; David P Bartel Journal: Nature Date: 2008-07-30 Impact factor: 49.962
Authors: Francine Einstein; Reid F Thompson; Tushar D Bhagat; Melissa J Fazzari; Amit Verma; Nir Barzilai; John M Greally Journal: PLoS One Date: 2010-01-26 Impact factor: 3.240
Authors: Pilar Rodríguez-Rodríguez; David Ramiro-Cortijo; Cynthia G Reyes-Hernández; Angel L López de Pablo; M Carmen González; Silvia M Arribas Journal: Front Physiol Date: 2018-05-23 Impact factor: 4.566